RCT for Yinqiaosan-Maxingganshitang in the Treatment of COVID-19
Condition: COVID-19 Interventions: Drug: Chinese Herb; Diagnostic Test: Placebo Sponsor: Chinese University of Hong Kong Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 28, 2023 Category: Research Source Type: clinical trials
Efficacy of silymarin in patients with non-alcoholic fatty liver disease — the Siliver trial: a study protocol for a randomized controlled clinical trial
This study has been approved by the Research Ethics Committee of the Professor Edgard Santos University Hospital Complex, Salvador BA, Brazil, under protocol 2.635.954. The study is carried out according to guidelines and regulatory standards for research involving humans, as set out in Brazilian legislation. Trial registration - ClinicalTrials.gov : NCT03749070. November 21, 2018 (Source: Trials)
Source: Trials - March 10, 2023 Category: Research Source Type: clinical trials
JING SI HERBAL TEA and Urinary Tract Symptoms in Bladder Cancer
Conditions: Lower Urinary Tract Symptoms; Intravenous Drug Usage; Bladder Cancer; Herbal Interaction Interventions: Dietary Supplement: JING SI HERBAL TEA; Dietary Supplement: Placebo Sponsor: Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 22, 2023 Category: Research Source Type: clinical trials
